ENDOCRINE PATHOLOGY

Scope & Guideline

Innovative Insights into Endocrine Disorders

Introduction

Immerse yourself in the scholarly insights of ENDOCRINE PATHOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1046-3976
PublisherHUMANA PRESS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationENDOCR PATHOL / Endocr. Pathol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512

Aims and Scopes

The journal 'Endocrine Pathology' focuses on the intricate field of endocrine and neuroendocrine tumors, providing a platform for research that integrates molecular biology, histopathology, and clinical practice. Its aims are to enhance the understanding of endocrine neoplasms, improve diagnostic accuracy, and contribute to the advancement of treatment methodologies.
  1. Molecular Pathology of Endocrine Tumors:
    The journal emphasizes the molecular mechanisms underpinning endocrine tumors, including genetic mutations, epigenetic changes, and their implications for diagnosis and prognosis.
  2. Integration of Clinical and Pathological Data:
    Research often combines clinical outcomes with histopathological features to better stratify risks and improve patient management in endocrine pathology.
  3. Emerging Diagnostic Techniques:
    The focus is on novel diagnostic methodologies such as immunohistochemistry, next-generation sequencing, and artificial intelligence applications in pathology.
  4. Neuroendocrine Tumor Classification and Management:
    The journal addresses the classification of neuroendocrine tumors and their clinical implications, aiming to refine treatment protocols and improve patient outcomes.
  5. Translational Research in Endocrine Oncology:
    There is a strong emphasis on translational research, bridging laboratory findings with clinical applications to enhance therapeutic strategies for endocrine malignancies.
Recent trends in 'Endocrine Pathology' publications highlight a dynamic shift towards innovative research themes that reflect the latest advancements in the field. These emerging topics are crucial for guiding future research and clinical practices.
  1. Genomic and Epigenomic Profiling:
    There is a growing focus on the genomic and epigenomic characterization of endocrine tumors, providing insights into tumor biology and potential therapeutic targets.
  2. Use of Artificial Intelligence in Pathology:
    Recent publications show an increasing trend in employing artificial intelligence for diagnostic purposes, enhancing the accuracy and efficiency of pathological assessments.
  3. Prognostic Biomarkers and Risk Stratification:
    Emerging studies are concentrating on identifying novel prognostic biomarkers that can aid in the risk stratification of patients with various endocrine tumors.
  4. Molecularly Targeted Therapies:
    Research is increasingly directed towards understanding the molecular basis of endocrine tumors for developing targeted therapies, reflecting a shift towards personalized medicine.
  5. Multidisciplinary Approaches in Treatment:
    There is a trend towards multidisciplinary treatment strategies that incorporate insights from pathology, oncology, and genetics to optimize patient management in endocrine neoplasms.

Declining or Waning

While 'Endocrine Pathology' maintains a robust focus on various aspects of endocrine tumors, certain themes appear to be losing prominence in recent publications. This decline may reflect shifts in research priorities or advancements in the field that render previous topics less relevant.
  1. Traditional Histopathological Techniques:
    There seems to be a waning interest in purely histopathological studies without molecular correlates, as the field increasingly values integrated molecular and clinical data.
  2. Generalized Reviews of Endocrine Tumors:
    There has been a noticeable decrease in broad review articles without specific novel insights or data, as the journal favors more focused, data-driven research.
  3. Outdated Diagnostic Criteria:
    With the evolving WHO classifications and advancements in molecular diagnostics, older diagnostic criteria and classifications are becoming less frequently discussed, indicating a shift towards contemporary methodologies.

Similar Journals

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Advancing the Science of Hormonal Regulation
Publisher: SPRINGERISSN: 0391-4097Frequency: 12 issues/year

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, published by SPRINGER, is a leading peer-reviewed journal dedicated to advancing the field of endocrinology. With a remarkable history dating back to 1978 and a convergence set until 2024, this journal serves as a vital source for researchers, clinicians, and students focusing on the intricate interplay of hormonal regulation and its implications for health and disease. The journal is recognized in the Q2 category for both Endocrinology and Endocrinology, Diabetes and Metabolism, highlighting its relevance and impact within the scientific community, exemplified by its strong Scopus rankings. While it does not offer open access, it ensures that high-quality research, reviews, and significant clinical findings are accessible to its readership. With a commitment to improving patient outcomes and elucidating complex biological mechanisms, the JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION remains a cornerstone publication for anyone involved in the study or practice of endocrinology.

Endocrinology Diabetes and Metabolism Case Reports

Empowering Research with Open Access Discoveries
Publisher: BIOSCIENTIFICA LTDISSN: Frequency: 1 issue/year

Endocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Pioneering insights into applied histology and pathology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1541-2016Frequency: 10 issues/year

Applied Immunohistochemistry & Molecular Morphology, published by Lippincott Williams & Wilkins, stands as a pivotal resource within the fields of histology, medical laboratory technology, and pathology. With an ISSN of 1541-2016 and an E-ISSN of 1533-4058, this journal has been contributing significant research and advancements since its inception in 1996. It serves a diverse audience, including researchers, professionals, and students, aiming to enhance the understanding of immunohistochemical techniques and molecular morphology. Recognized for its quality, it holds category quartiles of Q3 in histology and Q2 in medical laboratory technology and pathology and forensic medicine as of 2023. The journal's rigorous peer-review process ensures that only the most impactful findings are disseminated, thus advancing the education and practice in these critical domains of study. Though it is not an open-access journal, it remains essential for keeping abreast of the latest methodological innovations and applications in pathology and laboratory science, as evidenced by its respectable Scopus rankings and the continual convergence of groundbreaking research published through 2024.

Case Reports in Endocrinology

Pioneering case analyses for transformative endocrinology.
Publisher: HINDAWI LTDISSN: 2090-6501Frequency:

Case Reports in Endocrinology is a pioneering open access journal published by HINDAWI LTD, dedicated to advancing the field of endocrinology through the publication of case reports that illuminate the complexities of hormone-related disorders and metabolic issues. With its ISSN 2090-6501 and E-ISSN 2090-651X, the journal has been accessible since 2011, inviting contributions from researchers, clinicians, and students worldwide. Based in the United States, Case Reports in Endocrinology aims to disseminate critical insights and unique case analyses that contribute to the broader understanding of endocrinological conditions. While currently ranked Q4 in Endocrinology, Diabetes, and Metabolism, with Scopus placing it in the 29th percentile, the journal strives to enhance its impact and visibility. By fostering an environment for knowledge sharing and collaboration in a rapidly evolving field, this journal serves as an essential resource for those looking to deepen their understanding of endocrinological complexities and improve clinical practices.

ENDOCRINE RESEARCH

Advancing the frontiers of hormonal science.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

ADVANCES IN ANATOMIC PATHOLOGY

Empowering Researchers with Cutting-edge Findings.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1072-4109Frequency: 6 issues/year

ADVANCES IN ANATOMIC PATHOLOGY is a leading peer-reviewed journal dedicated to the field of anatomical pathology, published by LIPPINCOTT WILLIAMS & WILKINS. With an impressive impact factor and consistent ranking in the Q1 category for both Anatomy and Pathology and Forensic Medicine, it serves as an essential resource for researchers, clinicians, and students alike. The journal has been a critical platform for disseminating significant findings and advancements in the discipline since its inception in 1996, boasting Scopus rankings of #1 in Anatomy and #11 in Pathology. While it does not provide open access, it maintains rigorous standards in the selection of articles, ensuring that published research reflects the latest developments and techniques in the field. As we look toward 2024 and beyond, ADVANCES IN ANATOMIC PATHOLOGY remains committed to advancing the science of pathology, fostering innovation, and enhancing clinical practice through impactful research.

ENDOCRINE JOURNAL

Driving breakthroughs in endocrine research and therapy.
Publisher: JAPAN ENDOCRINE SOCISSN: 0918-8959Frequency: 12 issues/year

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.

International Journal of Endocrinology

Fostering collaboration to tackle endocrine challenges worldwide.
Publisher: HINDAWI LTDISSN: 1687-8337Frequency:

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.

Fetal and Pediatric Pathology

Navigating the challenges in fetal and pediatric medicine.
Publisher: TAYLOR & FRANCIS INCISSN: 1551-3815Frequency: 6 issues/year

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Nurturing Excellence in Endocrinology for Children
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.